Tyche Industries Limited (TYCHE.BO)
INR 144.15
(0.17%)
INR 144.15
(0.17%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 101.64 Million INR | -58.28% |
| 2022 | 243.63 Million INR | 51.8% |
| 2021 | 160.49 Million INR | -23.53% |
| 2020 | 209.88 Million INR | 19.49% |
| 2019 | 175.66 Million INR | 27.75% |
| 2018 | 137.5 Million INR | 1.12% |
| 2017 | 135.98 Million INR | 3.76% |
| 2016 | 131.05 Million INR | -40.01% |
| 2015 | 218.46 Million INR | 8.21% |
| 2014 | 201.88 Million INR | -33.29% |
| 2013 | 302.61 Million INR | -38.91% |
| 2012 | 495.35 Million INR | 140.39% |
| 2011 | 206.06 Million INR | -10.99% |
| 2010 | 231.49 Million INR | 243.57% |
| 2009 | 67.37 Million INR | -16.28% |
| 2008 | 80.48 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -1.26 Billion INR | -1346.89% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 101.64 Million INR | 0.0% |
| 2023 Q2 | 149.37 Million INR | 0.0% |
| 2023 FY | 101.64 Million INR | -58.28% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q2 | 200.3 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 243.63 Million INR | 0.0% |
| 2022 FY | 243.63 Million INR | 51.8% |
| 2022 Q1 | - INR | -100.0% |
| 2021 FY | 160.49 Million INR | -23.53% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 160.49 Million INR | 0.0% |
| 2021 Q2 | 157.24 Million INR | 0.0% |
| 2020 FY | 209.88 Million INR | 19.49% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 158.78 Million INR | 0.0% |
| 2020 Q4 | 209.88 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 155.09 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 175.66 Million INR | 27.75% |
| 2019 Q4 | 175.66 Million INR | 0.0% |
| 2018 Q2 | 140.02 Million INR | 0.0% |
| 2018 Q4 | 137.5 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 137.5 Million INR | 1.12% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 149.81 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 135.98 Million INR | 0.0% |
| 2017 FY | 135.98 Million INR | 3.76% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 131.05 Million INR | -40.01% |
| 2016 Q4 | 131.05 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 182.08 Million INR | 0.0% |
| 2015 FY | 218.46 Million INR | 8.21% |
| 2015 Q4 | 218.46 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 147.07 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q4 | 201.88 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 284.68 Million INR | 0.0% |
| 2014 FY | 201.88 Million INR | -33.29% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q4 | 302.61 Million INR | 0.0% |
| 2013 FY | 302.61 Million INR | -38.91% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 434.78 Million INR | 0.0% |
| 2012 Q4 | 495.35 Million INR | 0.0% |
| 2012 FY | 495.35 Million INR | 140.39% |
| 2011 FY | 206.06 Million INR | -10.99% |
| 2011 Q4 | 206.06 Million INR | 0.0% |
| 2010 FY | 231.49 Million INR | 243.57% |
| 2009 FY | 67.37 Million INR | -16.28% |
| 2008 Q4 | 80.48 Million INR | 0.0% |
| 2008 FY | 80.48 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.7 Million INR | -295.474% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 93.227% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 89.799% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -384.235% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -89.463% |
| Sunil Healthcare Limited | 902.83 Million INR | 88.742% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -4676.363% |
| MedPlus Health Services Limited | 14.27 Billion INR | 99.288% |
| Zenith Healthcare Limited | 24.03 Million INR | -322.887% |
| Patidar Buildcon Limited | 25.57 Million INR | -297.47% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | 34.453% |
| Roopa Industries Limited | 493.08 Million INR | 79.387% |
| Smruthi Organics Limited | 485.72 Million INR | 79.074% |
| Trident Lifeline Limited | 331.26 Million INR | 69.317% |
| Bacil Pharma Limited | 1.12 Million INR | -8902.746% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | 51.238% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | 37.132% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 89.88% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | 14.026% |
| PANJON LTD. | 25.38 Million INR | -300.429% |
| Trimurthi Limited | 101.36 Thousand INR | -100177.23% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -578.557% |
| Anuh Pharma Limited | 1.54 Billion INR | 93.42% |
| Crestchem Limited | 23.94 Million INR | -324.441% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -658.232% |
| Zenlabs Ethica Limited | 301.35 Million INR | 66.272% |
| Vikram Thermo (India) Limited | 291.47 Million INR | 65.129% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 93.883% |
| Parmax Pharma Limited | 117.56 Million INR | 13.547% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 94.539% |
| Deccan Health Care Limited | 111.33 Million INR | 8.708% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | 49.676% |
| Norris Medicines Limited | 278.17 Million INR | 63.461% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 94.071% |
| Veerhealth Care Limited | 62.78 Million INR | -61.9% |
| Makers Laboratories Limited | 569.18 Million INR | 82.143% |
| Lactose (India) Limited | 536.39 Million INR | 81.051% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 87.8% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 91.012% |
| Mercury Laboratories Limited | 171.18 Million INR | 40.626% |
| Gennex Laboratories Limited | 535.21 Million INR | 81.009% |
| PRAVEG LIMITED | 767.53 Million INR | 86.757% |
| Denis Chem Lab Limited | 289.82 Million INR | 64.93% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 94.078% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | 49.581% |
| Colinz Laboratories Limited | 24.1 Million INR | -321.659% |
| Godavari Drugs Limited | 957.86 Million INR | 89.389% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -33893.645% |
| Zenotech Laboratories Limited | 156.64 Million INR | 35.115% |
| Panchsheel Organics Limited | 340.2 Million INR | 70.123% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | 79.188% |
| Vivanza Biosciences Limited | 148.63 Million INR | 31.615% |
| Phaarmasia Limited | 211.49 Million INR | 51.942% |
| Bharat Parenterals Limited | 2.65 Billion INR | 96.174% |
| Medi-Caps Limited | 63.01 Million INR | -61.294% |
| DECIPHER LABS LIMITED | 117.72 Million INR | 13.662% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | 48.503% |
| BDH Industries Limited | 312.53 Million INR | 67.479% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | 41.975% |
| Coral Laboratories Limited | 281.83 Million INR | 63.937% |
| Concord Drugs Limited | 249.88 Million INR | 59.325% |
| Beryl Drugs Limited | 85.63 Million INR | -18.69% |
| Evoq Remedies Limited | 116.23 Million INR | 12.553% |
| Add-Shop E-Retail Limited | 159.2 Million INR | 36.157% |
| Transchem Limited | 6.72 Million INR | -1412.515% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -1045.638% |
| Parnax Lab Limited | 1.17 Billion INR | 91.318% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -142.164% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 90.39% |
| Cian Healthcare Limited | 1.03 Billion INR | 90.173% |
| Trinity League India Limited | 876 Thousand INR | -11502.854% |
| Syschem (India) Limited | 1.07 Billion INR | 90.507% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 95.025% |
| Natural Capsules Limited | 1.47 Billion INR | 93.119% |
| Auro Laboratories Limited | 433.09 Million INR | 76.532% |